Site Sponsors
  • Park Systems - Manufacturer of a complete range of AFM solutions
  • Oxford Instruments Nanoanalysis - X-Max Large Area Analytical EDS SDD
  • Strem Chemicals - Nanomaterials for R&D
Posted in | Nanoanalysis | Nanobusiness
20% off Mass Spectrometer range at Conquer Scientific

There are 2 related live offers.

Save 25% on magneTherm | 20% Off Mass Spectrometers | See All
Related Offers

New Report on Global Mass Spectrometry Market

Published on November 5, 2012 at 3:37 AM

Research and Markets has announced the addition of the "Global Mass Spectrometry Market 2011-2015" report to their offering.

TechNavio's analysts forecast the Global Mass Spectrometry market to grow at a CAGR of 7.83 percent over the period 2011-2015. One of the key factors contributing to this market growth is the increase in the revenue generated in the Biopharmaceutical segment which in turn has increased the purchasing capacity of this segment for mass spectrometers. The Global Mass Spectrometry market has also been witnessing a growth due to the Biopharmaceutical industry requirement to comply with regulations. However, the long replacement cycle of these devices pose a challenge to the growth of this market.

Key vendors dominating this market space include Agilent Technologies Inc., Bruker Corp. Danaher Corp., Thermo Fisher Scientific Inc., and Waters Corp.

Other vendors mentioned in the report: PerkinElmer Inc. and Shimadzu Corp.

Commenting on the report, an analyst from TechNavio's Hardware team said: ''One of the key trends in the Global Mass Spectrometry market is the use of mass spectrometers for the measurement of nanoparticles. Nanoparticles are ideally measured with the aid of transmission electron microscopes, which are extremely expensive. However, some laboratories have found a way to measure nanoparticles with the aid of a mass spectrometer, which is more cost-efficient.''

According to the report, one of the key drivers of this market is the growth in the revenue of the biopharmaceutical companies. Biopharmaceutical companies are key end-users of mass spectrometers. The growth in the revenue of these companies will encourage them to invest in more sophisticated measuring and testing tools such as mass spectrometers.

Source: http://www.researchandmarkets.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Submit